Myriad Genetics Inc
Current role
MYGN
Jennifer Fox
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Zenas BioPharma, Inc. (ZBIO)
SEC 8-K
Current2026-09-30–present
-
Current
-
Myriad Genetics Inc (MYGN)
Proxy statement
Current -
Current
-
Current
-
Start not stated–2024-08-16
-
Start not stated–2026-08-11
-
Start not stated–2023-11-27
-
Start not stated–2026-08-11
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Emergent BioSolutions Inc. (EBS) | Former Executive Vice President, External Affairs, General Counsel and Corporate Secretary | $472,658 | $1,189,933 |
| 2024 | Zenas BioPharma, Inc. (ZBIO) | Chief Business Officer and Chief Financial Officer Orlando Oliveira Chief Commercial Officer | $500,000 | $4,835,306 |
| 2023 | Emergent BioSolutions Inc. (EBS) | Former Executive Vice President, External Affairs, General Counsel and Corporate Secretary | $585,692 | $2,131,320 |
| 2023 | Zenas BioPharma, Inc. (ZBIO) | Chief Business Officer and Chief Financial Officer Orlando Oliveira Chief Commercial Officer | $40,064 | $2,566,608 |
| 2022 | Emergent BioSolutions Inc. (EBS) | Former Executive Vice President, External Affairs, General Counsel and Corporate Secretary | $473,544 | $2,923,207 |
| 2022 | Nuvation Bio Inc. (NUVB) | Chief Financial Officer | $546,000 | $3,974,694 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.